Episode Details:
Our Guest: Dr. Maria Maccecchini, CEO at Annovis Bio
What you’ll get out of this episode:
- Dr. Maccecchini’s background and how it led her to the founding of Annovis Bio?
- How she transitioned from academia to biosciences
- An overview of Annovis Bio’s approach and its lead compound?
- The data of the Buntanetap studies for Parkinson’s and Alzheimer’s
- The biggest challenges in working with neurodegenerative diseases like AD/PD
- What’s next for buntanetap?
- What is Annovis doing to enhance patient recruitment in clinical trials
- What’s next for Annovis Bio?
Watch
Listen
WORD FROM OUR SPONSORS:
Our sponsors for this episode are Sage Growth Partners & FlipMD
Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners
To learn more about Annovis Bio please use the links below:
Also, be sure to follow Slice of Healthcare on our social channels:
– Website – Facebook – LinkedIn – Twitter – YouTube – Newsletter
